Ventana anti-CD10 (SP67) Rabbit Monoclonal Primary Antibody, REF: 790-4506, IVD
Published August 28, 2024 · Recall initiated: June 27, 2024
Summary
FDA records medical device Class II recall Z-2644-2024, published August 28, 2024 and initiated June 27, 2024. Recalling firm: Ventana Medical Systems, Inc.; Status: Ongoing; Reported quantity: 22,839 kits; Lot: UDI: 04015630972579/J04613, J11853, J17541, J25047, J30286, K00982, K06239, K09880, K14266, K19784, K26461, and M00669. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Their is a potential for high background and off-target staining when using the monoclonal primary antibody which can result in false positive results.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Ventana Medical Systems, Inc.
- Distributor
- Worldwide - US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV and the countries of Austria, Belgium, Croatia, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Netherlands, Norway, Poland, Romania, Slovakia, Spain, Sweden, Switzerland, Albania, Argentina, Armenia, Australia, Azerbaijan, Bahrain, Belarus, Brazil, Cameroon, Chile, China, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, Egypt, El Salvador, Georgia, Ghana, Guatemala, Honduras, Hong Kong, India, Iran, Iraq, Israel, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kuwait, Lebanon, Malaysia, Mali, Mauritania, Mauritius, Mexico, Moldova, Mongolia, Morocco, Myanmar, Nepal, New Zealand, Nicaragua, Nigeria, North Macedonia, Oman, Pakistan, Palestine, Panama, Paraguay, Peru, Philippines, Russian Fed., Rwanda, Saudi Arabia, Serbia, Singapore, South Africa, South Korea, Sri Lanka, Taiwan, Tanzania, Thailand, T®rkiye, Uganda, United Arab Emirates, United Kingdom, Uruguay, and Vietnam.
- Lot
- UDI: 04015630972579/J04613, J11853, J17541, J25047, J30286, K00982, K06239, K09880, K14266, K19784, K26461, and M00669
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAnavify Digital Pathology (on-prem) v2.5, Material Number 10092343001 navify Digital Pathology (Cloud) v2.5.August 19, 2026
- FDATransfer Device, REF 2008S. Packaged on a form, fill and seal machine with a poly/Tyvek material then placedAugust 28, 2024
- FDAProduct Name: ClearCut S Safety Sideport Knife 1.0mm Dual Bevel Model/Catalog Number: 8065771540 SoftwareAugust 28, 2024
- FDAVial Decanter, REF 2006S. Packaged on a form, fill and seal machine with a poly/Tyvek material then placed 50August 28, 2024
- FDAProduct Name: 25GA VALVED ENTRY SYSTEM,3CT Model/Catalog Number: 8065751658 Software Version: N/A ProductAugust 28, 2024
- FDABottle Decanter, REF 2004S. Packaged on a form, fill and seal machine with a poly/Tyvek material then placedAugust 28, 2024
Questions about this recall
Was Ventana anti-CD10 (SP67) Rabbit Monoclonal Primary Antibody, REF: 790-4506, IVD recalled?
Yes. FDA published recall Z-2644-2024 on August 28, 2024. Reported hazard: Their is a potential for high background and off-target staining when using the monoclonal primary antibody which can result in false positive results.
What should I do if I have this product?
Voluntary: Firm initiated · Letter